Science Explorer Back to mapMap

Most cited papers from AcelRx Pharmaceuticals (United States)

What are the most cited papers from AcelRx Pharmaceuticals (United States)?

The most cited paper from AcelRx Pharmaceuticals (United States) is "Research design considerations for chronic pain prevention clinical trials" (Jennifer S. Gewandter et al., 2015), with 145 citations. Next come "Sufentanil Sublingual Tablet System vs. Intravenous Patient‐Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active‐Comparator Trial" (98) and "Current and Developing Methods of Patient-Controlled Analgesia" (95).

Showing 44 of 44 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Research design considerations for chronic pain prevention clinical trials Jennifer S. Gewandter et al. · Pain Open access 16 Apr 2015 145
2 Sufentanil Sublingual Tablet System vs. Intravenous Patient‐Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active‐Comparator Trial Timothy I. Melson, David L. Boyer, Harold S. Minkowitz et al. · Pain Practice Open access 25 Aug 2014 98
3 Current and Developing Methods of Patient-Controlled Analgesia Pamela Pierce Palmer, Ronald D. Miller · Anesthesiology Clinics 12 Nov 2010 95
4 Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations Sandra D. Comer et al. · Pain Open access 19 Sep 2012 74
5 Sufentanil Sublingual Tablet System for the Management of Postoperative Pain Following Open Abdominal Surgery Forrest G. Ringold, Harold S. Minkowitz, Tong Joo Gan et al. · Regional Anesthesia & Pain Medicine Open access 15 Oct 2014 56
6 Pharmacokinetics of Sublingual Sufentanil Tablets and Efficacy and Safety in the Management of Postoperative Pain Harold S. Minkowitz, Neil Singla, Mark A. Evashenk et al. · Regional Anesthesia & Pain Medicine 29 Dec 2012 49
7 Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations Alec O'connor et al. · Pain 19 Oct 2013 48
8 IV Acetaminophen Neil Singla, Martin E Hale, Jeffrey C. Davis et al. · American Journal of Therapeutics 10 Jan 2014 38
9 Pharmacokinetic Properties of Single- and Repeated-dose Sufentanil Sublingual Tablets in Healthy Volunteers Sandra K. Willsie, Mark A. Evashenk, Lawrence G. Hamel et al. · Clinical Therapeutics Open access 24 Dec 2014 37
10 Sublingual, transdermal and intravenous patient-controlled analgesia for acute post-operative pain: systematic literature review and mixed treatment comparison Pablo Katz, Shweta Takyar, Pamela Pierce Palmer et al. · Current Medical Research and Opinion Review 20 Mar 2017 36
11 Cost of opioid intravenous patient-controlled analgesia: results from a hospital database analysis and literature assessment Xiang Ji, Pamela Pierce Palmer, Jennifer L. Stephens · ClinicoEconomics and Outcomes Research Open access Jun 2014 35
12 Sufentanil sublingual tablet 30 mcg for moderate-to-severe acute pain in the ED James R. Miner, Zubaid Rafique, Harold S. Minkowitz et al. · The American Journal of Emergency Medicine Open access Nov 2017 34
13 Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations Jennifer S. Gewandter et al. · PAIN Reports Open access 2021 33
14 Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations Dennis C. Turk et al. · Pain Open access 5 Jul 2012 32
15 Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo‐Controlled, Phase‐3 Study Harold S. Minkowitz, David G. Leiman, Timothy I. Melson et al. · Pain Practice Open access 26 Oct 2016 31
16 Pooled Phase III Safety Analysis of Sufentanil Sublingual Tablets for Short-Term Treatment of Moderate-to-Severe Acute Pain James R. Miner, Timothy I. Melson, David G. Leiman et al. · Pain Management Open access 7 Jan 2019 26
17 Novel delivery systems for postoperative analgesia Pamela Pierce Palmer, Mike Allan Royal, Ronald D. Miller · Best practice & research. Clinical anaesthesiology Mar 2014 22
18 An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain Jacob L. Hutchins, David G. Leiman, Harold S. Minkowitz et al. · Pain Medicine Open access 13 Sep 2017 21
19 A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain Neil Singla, Derek D. Muse, Mark A. Evashenk et al. · The Journal of Trauma: Injury, Infection, and Critical Care 27 Aug 2014 20
20 Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe Montserrat Casamayor, Karen P. DiDonato, Marc Hennebert et al. · Drugs in Context Open access 10 Apr 2018 15
21 Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States David W. Boldt, Laurence W. Busse, Lakhmir S. Chawla et al. · Renal Failure Open access 11 Dec 2023 14
22 Pooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain Jacob L. Hutchins, David G. Leiman, Zubaid Rafique et al. · Journal of PeriAnesthesia Nursing Open access 12 Nov 2019 13
23 Cost of Intravenous Analgesia for the Management of Acute Pain in the Emergency Department is Substantial in the United States Pamela Pierce Palmer, Judith Anne Walker, Asad E. Patanwala et al. · Journal of health economics and outcomes research Open access 13 Mar 2017 7
24 Evolution of Patient-Controlled Analgesia: From Intravenous to Sublingual Treatment Julie Golembiewski, Joseph F. Dasta, Pamela Pierce Palmer · Hospital Pharmacy Open access Mar 2016 6
25 Patient and Healthcare Professional Satisfaction Ratings and Safety Profile of Sufentanil Sublingual Tablets for Treatment of Acute Pain: A Pooled Demographic Analysis David G. Leiman, Maurice Jové, Gail Rosen Spahn et al. · Journal of Pain Research Open access Mar 2021 5
26 (423) A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain Neil Singla, Derek D. Muse, Mark A. Evashenk et al. · Journal of Pain Open access 23 Mar 2014 4
27 Indirect treatment comparison of two non-invasive patient-controlled analgesia treatments for acute post-operative pain management Pablo Katz, Shweta Takyar, Pamela Pierce Palmer et al. · Current Medical Research and Opinion 15 Mar 2017 3
28 COST OF DELIVERING INTRAVENEOUS OPIOID ANALGESIA IN EMERGENCY DEPARTMENTS IN THE UNITED STATES Pamela Pierce Palmer, B. Lemus, Karen P. DiDonato et al. · Value in Health Open access May 2016 2
29 Sufentanil Sublingual Tablet System for the Management of Postoperative Pain After Knee or Hip Arthroplasty Maurice Jové, David W J Griffin, Harold S. Minkowitz et al. · Survey of Anesthesiology 25 Jan 2016 1
30 Intravenous (IV) Admnistration of Morphine For Moderate-To-Severe Acute Pain In The Emergency Room (ER) Setting Inflicts A Substantial Economic Burden In The EU5 Karen P. DiDonato, P. Palmer, T.M. Morris et al. · Value in Health Open access 31 Oct 2016 1
31 Phase 3 Efficacy and Safety Results of Sufentanil Sublingual 30 mcg Tablet for Management of Acute Traumatic Pain in Emergency Medicine James R. Miner, Harold S. Minkowitz, Zubaid Rafique et al. · Wilderness and Environmental Medicine Sep 2016 1
32 Zalviso™ (sufentanil sublingual microtablet system) efficacy and functionality following major abdominal surgery in young and elderly adult patients Forrest G. Ringold, Harold S. Minkowitz, Tong-Joo Gan et al. · Journal of the American College of Surgeons Oct 2014 1
33 Zalviso™ (sufentanil sublingual microtablet system) onset of action compared to IV patient-controlled analgesia with morphine: a phase III meta-analysis Harold S. Minkowitz, Tong-Joo Gan, Pamela Pierce Palmer · Journal of the American College of Surgeons Oct 2014 1
34 Patient-Controlled Analgesia: The Importance of Effector Site Pharmacokinetics Pamela Pierce Palmer, Mike Allan Royal Book chapter 23 Jul 2014 1
35 A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens Wiep Klaas Smits, Mia Urem, Annemieke H. Friggen et al. · Research Square PreprintOpen access 12 Jun 2025 0
36 I3 Efficacy and Tolerability of the Sufentanil Sublingual Tablet 30 mcg for Management of Acute Pain Karen P. DiDonato · Pain Management Nursing Apr 2018 0
37 Comparative Exploratory Analysis on Effectiveness, Tolerability And Patient/Nurse Satisfaction With Two Non-Invasive Patient Controlled Analgesia Treatments For Acute Post-Operative Pain Management Pablo Katz, Shweta Takyar, P. Palmer et al. · Value in Health Open access 31 Oct 2016 0
38 Cost Of Intraveneous Patient-Controlled Analgesia (Iv Pca) Equipment And Opioid Medication For Orthopedic And Abdominal Surgeries In United States Hospitals Xiang Ji, JM Stephens, Pamela Pierce Palmer · Value in Health Open access May 2014 0
39 (418) Sublingual sufentanil for acute pain management: onset of action Harold S. Minkowitz, Forrest G. Ringold, Timothy I. Melson et al. · Journal of Pain Open access 23 Mar 2014 0
40 Usability of the Sufentanil NanoTab PCA System: results from three human factors studies Mike Allan Royal, P. Palmer, B. Dasu et al. · Journal of Pain Open access 30 Mar 2013 0
41 A phase 3 multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Sufentanil NanoTab PCA System for the treatment of post-operative pain after open abdominal surgery Mike Allan Royal, Harold S. Minkowitz, Forrest G. Ringold et al. · Journal of Pain Open access 30 Mar 2013 0
42 A phase 3 non-inferiority trial comparing the Sufentanil NanoTab® PCA System to IV morphine PCA for the treatment of acute post-operative pain Mike Allan Royal, Ayşe Zeynep Turan, Timothy I. Melson et al. · Journal of Pain Open access 30 Mar 2013 0
43 (437) Sublingual sufentanil, an “ideal” opioid for acute and breakthrough pain: the clinical importance of CST½ and t½ke0 Tong Joo Gan, Pamela Pierce Palmer, Mike Allan Royal · Journal of Pain Open access 23 Mar 2014 0
44 Novel pharmaceuticals in the management of postoperative pain Pamela Pierce Palmer · Expert Review of Clinical Pharmacology 24 Jul 2015 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.